Symptomatic pulmonary hypertension in a child with sickle cell disease.

about

Non-congenital heart disease associated pediatric pulmonary arterial hypertension Vascular risk assessment in patients with sickle cell disease.

P2860

Q35165691-2EAD4B3F-9282-4ACD-9756-611A2270CB17 Q42558427-78B50A49-59FF-4A02-88DD-702191F67A18

P2860

Symptomatic pulmonary hypertension in a child with sickle cell disease.

Item

http://www.wikidata.org/entity/Q42783868

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@en

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@nl

type

Item

label

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@en

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@nl

prefLabel

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@en

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@nl

P1476

Symptomatic pulmonary hypertension in a child with sickle cell disease.

@en

P2093

Dunbar Ivy

http://www.w3.org/2001/XMLSchema#string

Karrie Villavicencio

http://www.w3.org/2001/XMLSchema#string

Laura Cole

http://www.w3.org/2001/XMLSchema#string

Rachelle Nuss

http://www.w3.org/2001/XMLSchema#string

P2860

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.

Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.

Biological activity of nitric oxide in the plasmatic compartment.

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

P304

879-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPEDS.2008.01.042

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5356925

http://www.w3.org/2001/XMLSchema#string

P698

18492535

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3128440

http://www.w3.org/2001/XMLSchema#string

Symptomatic pulmonary hypertension in a child with sickle cell disease.

about

P2860

P2860

Symptomatic pulmonary hypertension in a child with sickle cell disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932